Chargement en cours...
Overcoming Platinum Drug Resistance with Copper-lowering Agents
Platinum (Pt)-based antitumor agents have been the mainstay of cancer chemotherapy for the last three decades. While multiple mechanisms are responsible for treatment failure, deficiency in drug transport is an important contributor. The human high-affinity copper (Cu) transporter-1 (hCtr1) can also...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4001922/ https://ncbi.nlm.nih.gov/pubmed/24122978 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|